<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://tde.sagepub.com">
<title>The Diabetes Educator recent issues</title>
<link>http://tde.sagepub.com</link>
<description>The Diabetes Educator RSS feed -- recent issues</description>
<prism:publicationName>The Diabetes Educator</prism:publicationName>
<prism:issn>0145-7217</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/4/559?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/4/565?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/4/568?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/4/578?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/4/583?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/597?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/645?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/655?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/664?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/674?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/683?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/692?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/698?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/707?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/4/719?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/4/729?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_4/78S?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/Supplement_4/90S?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/369?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/373?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/375?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/378?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/393?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/439?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/445?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/451?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/3/457?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/3/477?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/3/484?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/3/493?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/3/501?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/3/511?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/3/518?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/3/535?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/54S?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/60S?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/66S?rss=1" />
  <rdf:li rdf:resource="http://tde.sagepub.com/cgi/reprint/34/Supplement_3/73S?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://tde.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://tde.sagepub.com:80/icons/banner/title.gif">
<title>The Diabetes Educator</title>
<url>http://tde.sagepub.com:80/icons/banner/title.gif</url>
<link>http://tde.sagepub.com</link>
</image>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/4/559?rss=1">
<title><![CDATA[AADE's 35th Annual Meeting and Exhibition 2008: Washington, DC]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/4/559?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Fain, J. A.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:title><![CDATA[AADE's 35th Annual Meeting and Exhibition 2008: Washington, DC]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>559</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>559</prism:startingPage>
<prism:section>Editorials</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/4/565?rss=1">
<title><![CDATA[AADE Making Progress: Announcing a New Structure for the Board of Directors]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/4/565?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Gonzalez, A.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:title><![CDATA[AADE Making Progress: Announcing a New Structure for the Board of Directors]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>566</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>565</prism:startingPage>
<prism:section>From the President</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/4/568?rss=1">
<title><![CDATA[AADE News]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/4/568?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:title><![CDATA[AADE News]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>574</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>568</prism:startingPage>
<prism:section>AADE News</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/4/578?rss=1">
<title><![CDATA[Looking Ahead]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/4/578?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:title><![CDATA[Looking Ahead]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>580</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>578</prism:startingPage>
<prism:section>Looking Ahead</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/4/583?rss=1">
<title><![CDATA[2008 Exhibition Preview (as of June 10, 2008): August 6-9 {middle dot} Washington, DC]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/4/583?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:title><![CDATA[2008 Exhibition Preview (as of June 10, 2008): August 6-9 {middle dot} Washington, DC]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>592</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>583</prism:startingPage>
<prism:section>2008 Exhibition Preview</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/597?rss=1">
<title><![CDATA[Diabetes and Disabilities: Assistive Tools, Services, and Information]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/597?rss=1</link>
<description><![CDATA[
<p>The purpose of this guide is to provide diabetes educators with a
comprehensive list of assistive tools, services, and information for diabetes
self-management for people with visual, manual, and hearing disabilities. A
list of tools and products has been compiled by members of the Disabilities
Specialty Practice Group (DSPG) and is updated periodically. The original list
was assembled in 1988 with the support of a grant from the Diabetes Research
and Education Foundation, Bridgewater, New Jersey. The last revised list was
titled "Diabetes Aids and Products for People With Visual or Physical
Impairment" and was published in <I>Diabetes Educ</I>.
1992;18:121-138. In addition to tools and products, organizations that provide
services and information for people with disabilities are provided to diabetes
educators.</p>
]]></description>
<dc:creator><![CDATA[Bartos, B. J., Cleary, M. E., Kleinbeck, C., Petzinger, R. A., Sokol-McKay, D. A., Whittington, A., Williams, A. S.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708322204</dc:identifier>
<dc:title><![CDATA[Diabetes and Disabilities: Assistive Tools, Services, and Information]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>636</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>597</prism:startingPage>
<prism:section>Tool Chest</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/645?rss=1">
<title><![CDATA[Review of Selected Chinese Herbal Medicines in the Treatment of Type 2 Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/645?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this article is to examine how Chinese herbal medicines are
used in the treatment of diabetes, focusing on potential benefits and
risks.</p>
<p>Methods</p>
<p>Medline, expert interviews, and Internet searches were used to identify
Chinese herbal medicines with antidiabetic properties and their
diabetes-related health claim, proposed antidiabetic effect, adverse effects,
contraindications, and drug interactions.</p>
<p>Results</p>
<p>Twenty-three herbs and 5 herbal formulas were selected for review.
Antidiabetic health claims included increasing serum insulin, decreasing blood
glucose, increasing glucose metabolism, and/or stimulating pancreatic
function. Side effects were few or not reported.</p>
<p>Conclusions</p>
<p>The use of Chinese herbal medicines in diabetes is promising but still far
from proven. Diabetes educators need to be aware of the risks and benefits of
herbal medicines. Patients should be asked about the use and source of herbal
medicines and carefully monitored for drug interactions and adverse
effects.</p>
]]></description>
<dc:creator><![CDATA[Wang, E., Wylie-Rosett, J.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708320559</dc:identifier>
<dc:title><![CDATA[Review of Selected Chinese Herbal Medicines in the Treatment of Type 2 Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>654</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>645</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/655?rss=1">
<title><![CDATA[Use of a Uniform Treatment Algorithm Abolishes Racial Disparities in Glycemic Control]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/655?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study is to compare glycemic control between blacks and
whites in a setting where patient and provider behavior is assessed, and where
a uniform treatment algorithm is used to guide care.</p>
<p>Methods</p>
<p>This observational cohort study was conducted in 3542 patients (3324
blacks, 218 whites) with type 2 diabetes with first and 1-year follow-up
visits to a municipal diabetes clinic; a subset had 2-year follow-up. Patient
adherence and provider management were determined. The primary endpoint was
A1c.</p>
<p>Results</p>
<p>At presentation, A1c was higher in blacks than whites (8.9% vs 8.3%;
<I>P</I> &lt; .001), even after adjusting for demographic and clinical
characteristics. During 1 year of follow-up, patient adherence to scheduled
visits and medications was comparable in both groups, and providers
intensified medications with comparable frequency and amount. After 1 year,
A1c differences decreased but remained significant (7.7% vs 7.3%; <I>P</I> =
.029), even in multivariable analysis (<I>P</I> = .003). However, after 2
years, A1c differences were no longer observed by univariate (7.6% vs 7.5%;
<I>P</I> = .51) or multi-variable analysis (<I>P</I> = .18).</p>
<p>Conclusions</p>
<p>Blacks have higher A1c than whites at presentation, but differences narrow
after 1 year and disappear after 2 years of care in a setting where patient
and provider behavior are comparable and that emphasizes uniform
intensification of therapy. Presumably, racial disparities at presentation
reflected prior inequalities in management. Use of uniform care algorithms
nationwide should help to reduce disparities in diabetes outcomes.</p>
]]></description>
<dc:creator><![CDATA[Rhee, M. K., Ziemer, D. C., Caudle, J., Kolm, P., Phillips, L. S.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708320903</dc:identifier>
<dc:title><![CDATA[Use of a Uniform Treatment Algorithm Abolishes Racial Disparities in Glycemic Control]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>663</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>655</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/664?rss=1">
<title><![CDATA[Do People With Diabetes Need Statins?]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/664?rss=1</link>
<description><![CDATA[
<p>The prevalence of type 2 diabetes mellitus continues to increase rapidly.
Persons with diabetes face a 2-fold greater absolute risk of cardiovascular
disease (CVD) than those without diabetes. Many diabetic patients die before
reaching the hospital after a cardiovascular event. Use of statin therapy for
intensive control of diabetic dyslipidemia has produced relative reductions in
CVD risk of about 25% in randomized, controlled clinical trials. This is true
even though low-density lipoprotein cholesterol, the primary target of statin
therapy, might not be markedly elevated in diabetic patients. Most patients
with diabetes or diabetes plus established CVD warrant intensive statin
therapy. Statin therapy has the ability to achieve low-density lipoprotein
cholesterol goals recommended in treatment guidelines. Alone or in combination
with an additional lipid-lowering drug, statins may also improve triglyceride
and high-density lipoprotein cholesterol abnormalities in patients with
diabetes.</p>
]]></description>
<dc:creator><![CDATA[White, J. R.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708320919</dc:identifier>
<dc:title><![CDATA[Do People With Diabetes Need Statins?]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>673</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>664</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/674?rss=1">
<title><![CDATA[Self-management in Type 2 Diabetes: The Adolescent Perspective]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/674?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study was to document barriers and facilitators of
self-management as perceived by adolescents with type 2 diabetes.</p>
<p>Methods</p>
<p>Focus groups were conducted with adolescents diagnosed with type 2
diabetes. Adolescents aged 13 to 19 years were recruited from an academic
medical center diabetes clinic. Between 2003 and 2005, 6 focus groups were
used to elicit responses from the adolescents related to self-management of
their diabetes. Questions were asked by trained group facilitators.
Transcripts were coded by 3 reviewers. Qualitative analyses were conducted
using NVIVO software.</p>
<p>Results</p>
<p>A total of 24 adolescents participated in 6 focus groups. Coding resulted
in 4 common domains affecting self-management: adolescent psychosocial
development; the role of others with diabetes; environmental influences; and
adolescents' problem-solving/coping skills. Adolescents identified both
barriers to and facilitators of self-management within each domain. Barriers
often related to social situations, embarrassment, seeking acceptance or
perceived normalcy, and balancing competing interests. Adolescents viewed
having another family member with diabetes as both a positive and a negative
influence. Environmental influences, including school and family situations,
had a large impact on self-management behaviors. Making sensible food choices
was a common challenge. Descriptions of problem-solving or coping skills were
limited, but cognitive techniques, such as reframing, were described.</p>
<p>Conclusion</p>
<p>Adolescents with type 2 diabetes identified many barriers to
self-management, particularly related to interpersonal interactions, the
influence of others with diabetes, and environmental influences. Results
suggest that improving self-management in adolescents may require multimodal
interventions to address individual, family, and social processes.</p>
]]></description>
<dc:creator><![CDATA[Mulvaney, S. A., Mudasiru, E., Schlundt, D. G., Baughman, C. L., Fleming, M., VanderWoude, A., Russell, W. E., Elasy, T. A., Rothman, R.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708320902</dc:identifier>
<dc:title><![CDATA[Self-management in Type 2 Diabetes: The Adolescent Perspective]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>682</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>674</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/683?rss=1">
<title><![CDATA[Hospitalization and Discharge Education of Emergency Department Patients With Hypoglycemia]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/683?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study is to evaluate the content and adequacy of
emergency department (ED) discharge instructions and factors associated with
hospitalization in patients presenting with hypoglycemia.</p>
<p>Methods</p>
<p>This is a retrospective cohort study at 3 adult EDs. A 1-year consecutive
sample of hypoglycemia cases were identified using ICD-9-CM codes and were
confirmed by chart review. Clinical variables and written discharge
instructions were analyzed by chart abstraction.</p>
<p>Results</p>
<p>Six hundred thirty-six charts of patients with possible hypoglycemia were
reviewed, of which 436 (64%) hypoglycemia cases were confirmed. The median age
was 64. Hypoglycemia was associated with sulfonylurea use for 78 (16%)
patients and insulin alone for 286 (65%) patients. Written discharge
instructions advised frequent blood glucose checks in 21% of patients and
medication dose adjustment in 27% of patients and rarely recommended avoiding
recurrent hypoglycemia (3%), checking glucose before driving (0.4%), or
obtaining glucagon emergency kits (2%). Hospitalization resulted from 177
(41%) visits and was associated with older age (age 65-74 [odds ratio 5.7] and
age &ge;75 [odds ratio 7.9]), sulfonylurea use (odds ratio 3.5), &ge;3
hypoglycemic episodes (odds ratio 3.1), no documented diabetes medications
(odds ratio 2.1), current primary care provider (odds ratio 4.2), and
hypoglycemia as a secondary diagnosis (odds ratio 4.7).</p>
<p>Conclusions</p>
<p>ED written discharge instructions appeared inadequate in providing
recommended education for patients with severe hypoglycemia. Older age and
sulfonylurea use were independently associated with hospital admission.
Although hypoglycemia is generally considered a self-limited condition, 2 of
every 5 patients required hospitalization, which likely reflects an older and
more complex patient population.</p>
]]></description>
<dc:creator><![CDATA[Ginde, A. A., Pallin, D. J., Camargo, C. A.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708321022</dc:identifier>
<dc:title><![CDATA[Hospitalization and Discharge Education of Emergency Department Patients With Hypoglycemia]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>691</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>683</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/692?rss=1">
<title><![CDATA[Barriers to Medication Adherence in Poorly Controlled Diabetes Mellitus]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/692?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study is to characterize the adherence and medication
management barriers for adults with poorly controlled type 2 diabetes mellitus
(DM) (those with A1c 9% or above) and to identify specific adherence
characteristics associated with poor diabetes control.</p>
<p>Methods</p>
<p>This was a cross-sectional analysis of baseline data from a randomized,
controlled diabetes intervention conducted in University of Washington (UW)
Medicine Clinics in the greater Seattle, Washington,
area.<sup><cross-ref type="bib" refid="ref1">1</cross-ref></sup> The goal of
the original study was to evaluate the effect of a pharmacist intervention on
improving diabetes control over 12 months. Evaluation measures for medication
adherence included self-reported adherence and medication management
challenges using the Morisky question
format<sup><cross-ref type="bib" refid="ref2">2</cross-ref></sup> and
difficulty with taking medications for each diabetes medication based on the
Brief Medication
Questionnaire.<sup><cross-ref type="bib" refid="ref3">3</cross-ref></sup>
Specific adherence characteristics associated with poor diabetes control (A1c
&gt;9%) were identified using multivariate regression analysis.</p>
<p>Results</p>
<p>Seventy-seven subjects (mean A1c, 10.4%; mean duration of DM, 7 years) were
studied. The most common adherence challenges included paying for medications
(34%), remembering doses (31%), reading prescription labels (21%), and
obtaining refills (21%). Taking morethan 2 doses of DM medication daily
(&beta; = .78, SE = 0.32, <I>P</I> = .02) and difficulty reading the DM
medication prescription label (&beta; = .76, SE = 0.37, <I>P</I> = .04) were
significantly associated with higher hemoglobin A1c. Self-reported adherence
was not related to A1c control.</p>
<p>Conclusions</p>
<p>In this study, we identified 2 factors that were associated with poorer A1c
control. These findings highlight the importance of identifying potential
challenges to medication adherence for those with DM and providing support to
minimize or resolve these barriers to control.</p>
]]></description>
<dc:creator><![CDATA[Odegard, P. S., Gray, S. L.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708320558</dc:identifier>
<dc:title><![CDATA[Barriers to Medication Adherence in Poorly Controlled Diabetes Mellitus]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>697</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>692</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/698?rss=1">
<title><![CDATA[Improved Clinical Outcomes Using a Culturally Sensitive Diabetes Education Program in a Hispanic Population]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/698?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study was to evaluate the effects of a culturally
sensitive diabetes education program for Hispanics with type 2 diabetes.</p>
<p>Methods</p>
<p>This study is a prospective cohort study to test the impact of a
comprehensive diabetes education program on blood glucose control on Hispanics
with type 2 diabetes. The educational program focused on maintaining glycemic
control and general aspects of managing diabetes and complications. The study
participants were recruited by flyers placed in Hispanic markets and in
ambulatory care clinics. A total of 34 Hispanic male and female subjects with
type 2 diabetes participated in the study. The concentrations of glucose,
insulin, hemoglobin A1c (HbA1c), total cholesterol, triglycerides, low-density
lipoprotein and high-density lipoprotein (HDL) cholesterol were analyzed at
baseline and at 3 months.</p>
<p>Results</p>
<p>A significant mean change was observed for HbA1c, fasting plasma glucose,
cholesterol/HDL ratio, and HDL after 3 months of education compared with
baseline. There were significant reductions in weight, total fat, percent fat,
trunk fat, and waist-to-hip ratio compared with baseline. After 3 months,
subjects showed a significant positivecorrelation between changes in body mass
index and insulin and weight, total fat, trunk fat, and fat free mass and
insulin.</p>
<p>Conclusions</p>
<p>A culturally sensitive program conducted in Spanish had a significant
impact on important clinical parameters in Hispanic subjects with diabetes in
a relatively short time period. The study demonstrates the importance of
designing education intervention studies that are sensitive to cultural
diversity, particularly in at-risk diabetic subjects.</p>
]]></description>
<dc:creator><![CDATA[Metghalchi, S., Rivera, M., Beeson, L., Firek, A., De Leon, M., Cordero-MacIntyre, Z. R., Balcazar, H.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708320913</dc:identifier>
<dc:title><![CDATA[Improved Clinical Outcomes Using a Culturally Sensitive Diabetes Education Program in a Hispanic Population]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>706</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>698</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/707?rss=1">
<title><![CDATA[Development and Validation of an Instrument to Measure Resources and Support for Chronic Illness Self-management: A Model Using Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/707?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>Few comprehensive and practical instruments exist to measure the receipt of
self-management support for chronic illness. An instrument was developed to
measure resources and support for self-management (RSSM) for the survey
component of the evaluation of the Robert Wood Johnson Foundation's Diabetes
Initiative. It includes items to measure an ecological range of RSSM. This
article describes the development and validation of the instrument, focusing
on individuals' reported access to RSSM from providers and from nonclinical,
social, and community sources.</p>
<p>Methods</p>
<p>Cross-sectional analyses of the second wave of a survey of participants in
the Diabetes Initiative (68% response rate, n = 957) were used.</p>
<p>Results</p>
<p>Confirmatory factor analyses supported grouping the 17 items into 5
subscales, measuring key aspects of RSSM: individualized assessment,
collaborative goal setting, enhancing skills, ongoing follow-up and support,
and community resources (comparative fit index = 0.97, Tucker-Lewis fit index
= 0.99, and root meansquare error of approximation = 0.06). The overall scale
and 5 subscales were internally consistent (Cronbach  &ge; .70) and
were significantly, positively related to diabetes self-management behaviors,
supporting their construct validity.</p>
<p>Conclusions</p>
<p>This instrument shows promise for measuring RSSM. Although it was developed
for diabetes programs, its ecological orientation and link to the broad
framework of chronic care suggest broader application.</p>
]]></description>
<dc:creator><![CDATA[McCormack, L. A., Williams-Piehota, P. A., Bann, C. M., Burton, J., Kamerow, D. B., Squire, C., Fisher, E., Brownson, C. A., Glasgow, R. E.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708321021</dc:identifier>
<dc:title><![CDATA[Development and Validation of an Instrument to Measure Resources and Support for Chronic Illness Self-management: A Model Using Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>718</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>707</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/4/719?rss=1">
<title><![CDATA[Self-Efficacy, Social Support, and Associations With Physical Activity and Body Mass Index Among Women With Histories of Gestational Diabetes Mellitus]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/4/719?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>To examine the associations between 2 potential facilitators of healthy
behaviors (self-efficacy and social support), and both physical activity and
body mass index (BMI) among women with histories of gestational diabetes
mellitus (GDM).</p>
<p>Methods</p>
<p>Two hundred and twenty-eight women with histories of GDM who were enrolled
in a managed care plan were surveyed. A cross-sectional analysis was used to
assess the association between women's social support from family and friends
for physical activity and self-efficacy for physical activity with women's
physical activity levels. The association between women's social support from
family and friends for healthy diet and self-efficacy for not overeating and
their dietary habits also were examined. Finally, the association between all
of these psychosocial constructs and body mass index (BMI) were assessed
before and after adjustment for covariates.</p>
<p>Results</p>
<p>Participants reported low to moderate social support and self-efficacy
scores, suboptimal performance of physical activity, suboptimal dietary
scores, and high BMIs. Self-efficacy and social support from family and
friends for physical activity were associated with physical activity. Social
support from family and friends for a healthy diet was associated with better
dietary scores, and the association between self-efficacy for not overeating
and healthy diet bordered on significance. No significant associations existed
between psychosocial constructs and BMI.</p>
<p>Conclusions</p>
<p>Psychosocial constructs such as social support and self-efficacy are
associated with physical activity and dietary habits. However, associations
with BMI are weak. Further exploration of constructs associated with BMI may
be needed to design effective weight-loss interventions in this
population.</p>
]]></description>
<dc:creator><![CDATA[Kim, C., McEwen, L. N., Kieffer, E. C., Herman, W. H., Piette, J. D.]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:identifier>info:doi/10.1177/0145721708321005</dc:identifier>
<dc:title><![CDATA[Self-Efficacy, Social Support, and Associations With Physical Activity and Body Mass Index Among Women With Histories of Gestational Diabetes Mellitus]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>728</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>719</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/4/729?rss=1">
<title><![CDATA[Insulin Delivery Systems]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/4/729?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-07-31</dc:date>
<dc:title><![CDATA[Insulin Delivery Systems]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>731</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>729</prism:startingPage>
<prism:section>Industry Update</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_4/78S?rss=1">
<title><![CDATA[Multidisciplinary Interventions: Mapping New Horizons in Diabetes Care]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/Supplement_4/78S?rss=1</link>
<description><![CDATA[
<p>More than 20 million people in the United States, or 7% of the population,
have diabetes, with health care and work-related costs estimated to be $174
billion in 2007. Obesity constitutes one of the major driving factors behind
this epidemic.</p>
<p>Most drugs currently used to treat diabetes address the primary metabolic
defects in type 2 diabetes mellitus, which are insulin resistance and
pancreatic islet dysfunction. Incretin augmentation therapies, such as
glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase IV
inhibitors, restore glucose homeostasis by addressing some of the unmet needs
in diabetes therapies related to -cell dysfunction and chronic
&beta;-cell dysfunction. This new group of drugs offers certain advantages
because its use is characterized by a low incidence of hypoglycemia and the
absence of weight gain. Moreover, the use of fixed-dose combinations of
dipeptidyl peptidase IV inhibitors with other oral antidiabetic agents seems
very attractive to patients because of their reduced pill intake and minimized
financial burden, which may improve adherence.</p>
<p>An efficient strategy to slow down the epidemic of diabetes must include
these emerging therapies and regimens, coupled with intensive patient
education that includes information on treatment benefits and adverse effects,
medication costs, and medication regimen complexity.</p>
]]></description>
<dc:creator><![CDATA[Horton, E., Cefalu, W. T., Haines, S. T., Siminerio, L. M.]]></dc:creator>
<dc:date>2008-07-29</dc:date>
<dc:identifier>info:doi/10.1177/0145721708321148</dc:identifier>
<dc:title><![CDATA[Multidisciplinary Interventions: Mapping New Horizons in Diabetes Care]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>Supplement 4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>89S</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>78S</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/Supplement_4/90S?rss=1">
<title><![CDATA[Posttest Questions]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/Supplement_4/90S?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-07-29</dc:date>
<dc:title><![CDATA[Posttest Questions]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>Supplement 4</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>91S</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>90S</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/369?rss=1">
<title><![CDATA[The Law, School, and Child With Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/369?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Fain, J. A.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/</dc:identifier>
<dc:title><![CDATA[The Law, School, and Child With Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>369</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>369</prism:startingPage>
<prism:section>Editorials</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/373?rss=1">
<title><![CDATA[Diabetes Education for All!]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/373?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Gonzalez, A.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/</dc:identifier>
<dc:title><![CDATA[Diabetes Education for All!]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>373</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>373</prism:startingPage>
<prism:section>From the President</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/375?rss=1">
<title><![CDATA[AADE News]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/375?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:title><![CDATA[AADE News]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>376</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>375</prism:startingPage>
<prism:section>AADE News</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/378?rss=1">
<title><![CDATA[Looking Ahead]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/378?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:title><![CDATA[Looking Ahead]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>380</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>378</prism:startingPage>
<prism:section>Looking Ahead</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/393?rss=1">
<title><![CDATA[2008 EXHIBITION PREVIEW (as of March 19, 2008): August 6-9 {middle dot} Washington, DC]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/393?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:title><![CDATA[2008 EXHIBITION PREVIEW (as of March 19, 2008): August 6-9 {middle dot} Washington, DC]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>438</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>393</prism:startingPage>
<prism:section>2008 Exhibition Preview</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/439?rss=1">
<title><![CDATA[Management of Children With Diabetes in the School Setting]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/439?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708317873</dc:identifier>
<dc:title><![CDATA[Management of Children With Diabetes in the School Setting]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>443</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>439</prism:startingPage>
<prism:section>AADE Position Statement</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/445?rss=1">
<title><![CDATA[AADE7TM Self-Care Behaviors]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/445?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708316625</dc:identifier>
<dc:title><![CDATA[AADE7TM Self-Care Behaviors]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>449</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>445</prism:startingPage>
<prism:section>AADE Position Statement</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/451?rss=1">
<title><![CDATA[Diabetes Educators: Implementing the Chronic Care Model]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/451?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708316627</dc:identifier>
<dc:title><![CDATA[Diabetes Educators: Implementing the Chronic Care Model]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>456</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>451</prism:startingPage>
<prism:section>AADE Position Statement</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/3/457?rss=1">
<title><![CDATA[Choosing and Using Citation and Bibliographic Database Software (BDS)]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/3/457?rss=1</link>
<description><![CDATA[
<p>The diabetes educator/researcher is faced with a proliferation of diabetes
articles in various journals, both online and in print. Keeping track of cited
references and remembering how to cite the references in text and the
bibliography can be a daunting task for the new researcher and a tedious task
for the experienced researcher. The challenge is to find and use a technology,
such as bibliographic database software (BDS), which can help to manage this
information overload. This article focuses on the use of BDS for the diabetes
educator who is undertaking research. BDS can help researchers access and
organize literature and make literature searches more efficient and less time
consuming. Moreover, the use of such programs tends to reduce errors
associated with the complexity of bibliographic citations and can increase the
productivity of scholarly publications. The purpose of this article is to
provide an overview of BDS currently available, describe how it can be used to
aid researchers in their work, and highlight the features of different
programs. It is important for diabetes educators and researchers to explore
the many benefits of such BDS programs and consider their use to enhance the
accuracy and efficiency of accessing and citing references of their research
work and publications. Armed with this knowledge, researchers will be able to
make informed decisions about selecting BDS which will meet their usage
requirements.</p>
]]></description>
<dc:creator><![CDATA[Hernandez, D. A., El-Masri, M. M., Hernandez, C. A.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708317875</dc:identifier>
<dc:title><![CDATA[Choosing and Using Citation and Bibliographic Database Software (BDS)]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>474</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>457</prism:startingPage>
<prism:section>Research Update</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/3/477?rss=1">
<title><![CDATA[School-Age Children With Diabetes: Role of Maternal Self-Efficacy, Environment, and Management Behaviors]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/3/477?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study was to examine the relationships between maternal
environment (child behavior and coping resources), diabetes self-efficacy,
diabetes management behaviors, and child glycemic control.</p>
<p>Methods</p>
<p>Study participants were recruited from 3 outpatient clinics in the Midwest
and included 41 mothers of children with type 1 diabetes, ages 6 to 10. All
participants completed the following measures: Coping Resources Inventory,
Behavioral Assessment System for Children-Parent Report, Maternal
Self-Efficacy for Diabetes Scale, Diabetes Management Scale&mdash;Parent, and
24-hour diabetes behavior recall. Downloaded glucose data and child HgbA1c
were obtained by chart review. Stepwise multiple regression was used to
determine the influence of maternal environment on maternal diabetes
self-efficacy and diabetes management behavior. Pearson product moment
correlations were used to determine if relationships existed between maternal
self-efficacy, diabetes management behaviors, and child metabolic control.</p>
<p>Results</p>
<p>Coping resources contributed significantly to mothers' diabetes
self-efficacy. No significant relationship was found between the mothers'
environment and diabetes management behavior. Self-efficacy did not predict
maternal diabetes management behaviors. The blood glucose testingand maternal
recall of diabetes behaviors were correlated to metabolic control.</p>
<p>Conclusions</p>
<p>Mothers with coping resources felt more confident in managing their
children's diabetes. Child behavior did not influence a mother's diabetes
management behaviors. Mothers who were consistent in their diabetes management
behaviors had children in better metabolic control. More information is needed
to determine what mothers view as barriers in providing diabetes care for
their children.</p>
]]></description>
<dc:creator><![CDATA[Marvicsin, D.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708316944</dc:identifier>
<dc:title><![CDATA[School-Age Children With Diabetes: Role of Maternal Self-Efficacy, Environment, and Management Behaviors]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>483</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>477</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/3/484?rss=1">
<title><![CDATA[Perceptions of Coronary Heart Disease Risk in Korean Immigrants With Type 2 Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/3/484?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study was to examine coronary heart disease (CHD) risk
perception, risk factor status, and factors associated with CHD risk
perception in Korean immigrants with type 2 diabetes mellitus.</p>
<p>Methods</p>
<p>A community sample of 143 Korean adults with type 2 diabetes, aged 30 to 80
years old, completed questionnaires and biological measures. A multiple
regression analysis was conducted to evaluate the relationships between CHD
knowledge, general health, smoking, medications for CHD risk factors,
demographic variables (independent variables), and the perception of CHD risk
(dependent variable).</p>
<p>Results</p>
<p>Participants had low perception of CHD risk, with most (76.9%) indicating
their risk to be the same or lower than people of the same age and sex in the
general population. Overall, CHD risk factor control was suboptimal according
to American Diabetes Association guidelines. Only 41.3% of participants met
the HbA1c goal of less than 7%. More than half (55%) had uncontrolled blood
pressure, and a similar proportion (53.6%) had higher low-density lipoprotein
cholesterol than the target goal. CHD knowledge and self-reported general
health influenced the perception of CHD risk. More CHD knowledge and poor
general health were associated with higher perception of CHD risk.</p>
<p>Conclusions</p>
<p>To increase the perception of CHD risk in Korean immigrants with type 2
diabetes, diabetes educators and clinicians should educate such patients about
CHD risk factors and discuss their risk status at every visit. Those who
report their health to be good deserve particular attention.</p>
]]></description>
<dc:creator><![CDATA[Choi, S., Rankin, S., Stewart, A., Oka, R.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708316949</dc:identifier>
<dc:title><![CDATA[Perceptions of Coronary Heart Disease Risk in Korean Immigrants With Type 2 Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>492</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>484</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/3/493?rss=1">
<title><![CDATA[The Behavior and Psychological Functioning of People at High Risk of Diabetes-Related Foot Complications]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/3/493?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this review was to propose a model that describes the
influences on the behavior and psychological functioning of people at risk for
diabetes-related foot complications.</p>
<p>Methods</p>
<p>A literature search was conducted in Medline (1950-2005), CINAHL
(1982-2005), and PsycInfo (1967-2005) databases and in reference lists of
journal articles and relevant books. The search focused on published
literature in the English language that was related to concepts such as
diabetes-related foot complications, behavior, and psychology.</p>
<p>Results</p>
<p>The literature reviewed was arranged to reflect the reciprocal relationship
between the personal, environmental, and behavioral factors of people at risk
of diabetes-related foot complications. The model proposed uses the concept of
reciprocal determinism to illustrate how these factors interact and influence
the development of diabetes-related foot complications.</p>
<p>Conclusion</p>
<p>The concept of reciprocal determinism may be useful when developing further
investigation into educational and behavioral interventions in this clinical
population.</p>
]]></description>
<dc:creator><![CDATA[Perrin, B., Swerissen, H.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708316945</dc:identifier>
<dc:title><![CDATA[The Behavior and Psychological Functioning of People at High Risk of Diabetes-Related Foot Complications]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>500</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>493</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/3/501?rss=1">
<title><![CDATA[Coping Styles, Well-Being, and Self-Care Behaviors Among African Americans With Type 2 Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/3/501?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study was to describe how coping styles among African
Americans with type 2 diabetes relate to diabetes appraisals, self-care
behaviors, and health-related quality of life or well-being.</p>
<p>Methods</p>
<p>This cross-sectional analysis of baseline measures from 185 African
Americans with type 2 diabetes enrolled in a church-based randomized
controlled trial uses the theoretical framework of the transactional model of
stress and coping to describe bivariate and multivariate associations among
coping styles, psychosocial factors, self-care behaviors, and well-being, as
measured by validated questionnaires.</p>
<p>Results</p>
<p>Among participants who were on average 59 years of age with 9 years of
diagnosed diabetes, passive and emotive styles of coping were used most
frequently, with older and less educated participants using more often passive
forms of coping. Emotive styles of coping were significantly associated with
greater perceived stress, problem areas in diabetes, and negative appraisals
of diabetes control. Both passive and active styles of coping were associated
with better diabetes self-efficacy and competence in bivariate analysis. In
multivariate analysis, significant proportions of the variance in dietary
behaviors and mental well-being outcomes (general and diabetes specific) were
explained, with coping styles among the independent predictors. A positive
role for church involvement in the psychological adaptation to living with
diabetes was also observed.</p>
<p>Conclusions</p>
<p>In this sample of older African Americans with diabetes, coping styles were
important factors in diabetes appraisals, self-care behaviors, and
psychological outcomes. These findings suggest potential benefits in
emphasizing cognitive and behavioral strategies to promote healthy coping
outcomes in persons living with diabetes.</p>
]]></description>
<dc:creator><![CDATA[Samuel-Hodge, C. D., Watkins, D. C., Rowell, K. L., Hooten, E. G.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708316946</dc:identifier>
<dc:title><![CDATA[Coping Styles, Well-Being, and Self-Care Behaviors Among African Americans With Type 2 Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>510</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>501</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/3/511?rss=1">
<title><![CDATA[Measuring Psychological Insulin Resistance: Barriers to Insulin Use]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/3/511?rss=1</link>
<description><![CDATA[
<p>Purpose</p>
<p>The purpose of this study is to explore the attitudes that contribute to
psychological insulin resistance (PIR) in insulin-naive patients with type 2
diabetes and to identify predictors of PIR.</p>
<p>Methods</p>
<p>A prospective study using 2 self-report surveys and incorporating
demographic and health variables was conducted to determine the prevalence of
PIR among a sample of 100 adult, insulin-naive patients with type 2 diabetes
at an outpatient diabetes center in a university-affiliated teaching
hospital.</p>
<p>Results</p>
<p>Thirty-three percent of patients with type 2 diabetes were unwilling to
take insulin. The most commonly expressed negative attitudes were concern
regarding hypoglycemia, permanent need for insulin therapy, less flexibility,
and feelings of failure. Less than 40% expressed fear of self-injection or
thought that injections were painful. However, compared with willing subjects,
unwilling subjects were more likely to fear injections and thought injections
would be painful, life would be less flexible, and taking insulin meant health
would deteriorate (<I>P</I> &lt; .005 for all comparisons). Poorer general
health and higher depression scores also correlated with PIR.</p>
<p>Conclusions</p>
<p>The results of the surveys, which were generally consistent, identified
several remediable misconceptions regarding insulin therapy and suggest
targets for educational interventions.</p>
]]></description>
<dc:creator><![CDATA[Larkin, M. E., Capasso, V. A., Chen, C.-L., Mahoney, E. K., Hazard, B., Cagliero, E., Nathan, D. M.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708317869</dc:identifier>
<dc:title><![CDATA[Measuring Psychological Insulin Resistance: Barriers to Insulin Use]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>517</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>511</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/3/518?rss=1">
<title><![CDATA[More Choices Than Ever Before: Emerging Therapies for Type 2 Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/3/518?rss=1</link>
<description><![CDATA[
<p>The goal of antidiabetes therapy is to reduce glycosylated hemoglobin
(HbA<SUB>1c</SUB>) levels to prevent or minimize the microvascular
complications associated with this disease, such as retinopathy, nephropathy,
and neuropathy. Glycemic control, defined by the American Diabetes Association
(ADA) as HbA<SUB>1c</SUB> &lt; 7.0%, is often difficult to achieve despite
current treatments, including oral antidiabetes agents, such as biguanides
(metformin), sulfonylureas, thiazolidinediones, dipeptidyl peptidase-IV
(DPP-IV) inhibitors, meglitinides, and -glucosidase inhibitors, as well
as injectable agents, such as glucagon-like peptide-1 (GLP-1) analogues and
insulin. In addition, antidiabetes treatments often become less effective over
time as insulin resistance increases and pancreatic &beta;-cell function
deteriorates. The latest ADA guidelines also recommend a range of
interventions to control the multiple coexisting conditions associated with
this chronic, progressive disease, including dyslipidemia and hypertension.
This review highlights the new antidiabetes drug classes, which include
incretin mimetics, cannabinoid receptor type 1 antagonists, and bile acid
sequestrants, and compares these agents to established treatments with regard
to efficacy and tolerability. The more recently developed antidiabetes drugs
have been shown in clinical trials to produce glucose-lowering effects similar
to those of established antidiabetes agents. Many of the new antidiabetes
agents can be safely combined with established therapies to further improve
glycemic control. In addition, the new agents may provide additional
significant cardiometabolic benefits, including improving the lipid profile,
lowering blood pressure, and reducing body weight. These new treatments may
have the potential to greatly improve the management of type 2 diabetes.</p>
]]></description>
<dc:creator><![CDATA[Campbell, R. K., White, J. R.]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:identifier>info:doi/10.1177/0145721708317870</dc:identifier>
<dc:title><![CDATA[More Choices Than Ever Before: Emerging Therapies for Type 2 Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>534</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>518</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/3/535?rss=1">
<title><![CDATA[Medication Management]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/3/535?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-05</dc:date>
<dc:title><![CDATA[Medication Management]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>537</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>535</prism:startingPage>
<prism:section>Industry Update</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/54S?rss=1">
<title><![CDATA[Clinical Pearls and Strategies to Optimize Patient Outcomes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/54S?rss=1</link>
<description><![CDATA[
<p>Increasing evidence suggests that a large proportion of patients with type
2 diabetes do not meet glycemic targets. Early diagnosis, realistic goal
setting, improved patient adherence, and a better understanding of the
pharmacotherapeutic treatment options are crucial to improving diabetes
treatment outcomes in the United States. There are many reasons why patients
do not achieve glycemic control. Barriers faced by clinicians, such as
clinical inertia, lack of education time, and inappropriate use and titration
of medications, need to be overcome to improve patient care. At the same time,
patients are challenged by lifestyle management, lack of understanding of
therapeutic options, and failing to see themselves as partners in their own
care. Successful diabetes management programs incorporate several key
features, including proactive reminders, consistent follow-up procedures, and
use of clinical information systems to improve patient adherence and overall
quality of care. Both clinicians and patients face barriers to advancing to
injectable medications. Patients' attitudes may include fears of injections,
technical challenges, and "punishment" for "failing"
treatment. Clinicians have concerns about inadequate resources to address the
needs of patients, patient nonadherence, and hypoglycemic events associated
with certain injectable medications. Many of the strategies to overcome these
barriers are reviewed.</p>
]]></description>
<dc:creator><![CDATA[Joy, S. V.]]></dc:creator>
<dc:date>2008-06-04</dc:date>
<dc:identifier>info:doi/10.1177/0145721708319233</dc:identifier>
<dc:title><![CDATA[Clinical Pearls and Strategies to Optimize Patient Outcomes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>Supplement 3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>59S</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>54S</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/60S?rss=1">
<title><![CDATA[Exploring the Pharmacotherapeutic Options for Treating Type 2 Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/60S?rss=1</link>
<description><![CDATA[
<p>There has been a dramatic increase in the prevalence of the most common
form of diabetes, with approximately 14.6 million diagnosed and 6.2 million
undiagnosed cases of type 2 (non-insulin-dependent) diabetes in the United
States since 2005. If diabetes is not diagnosed early and managed properly,
patients are at greater risk for microvascular and macrovascular
complications, such as nerve damage, heart disease, blindness, and kidney
damage. The pathogenesis of type 2 diabetes includes impaired insulin
secretion, increased hepatic and muscle/fat insulin resistance, and increased
glucagon secretion. Problems commonly associated with type 2 diabetes and
consequent hyperglycemia are weight gain, hypertension, and dyslipidemia. The
natural progression of type 2 diabetes involves increased insulin deficiency
as a result of decreased beta cell function over time, which can raise
glycosylated hemoglobin to dangerous levels and consequently increase the risk
of death. Lifestyle modifications (eg, diet changes and increased physical
activity) remain the cornerstone of early treatment, but glycemic control may
worsen despite behavior changes and treatment with oral hypoglycemic agents.
Historically, upon failure to maintain glucose levels with exercise and oral
medication, insulin was the second-line treatment option. Current treatment
algorithms include a new class of agents, incretin mimetics, such as the
glucagon-like peptide-1 (GLP-1) receptor agonist exenatide. Exenatide mimics
the actions of the hormone GLP-1 that occurs naturally in the gastrointestinal
tract and has emerged as an efficacious therapy adjunct to 1 or more oral
hypoglycemic agent(s).</p>
]]></description>
<dc:creator><![CDATA[Kruger, D. F.]]></dc:creator>
<dc:date>2008-06-04</dc:date>
<dc:identifier>info:doi/10.1177/0145721708319234</dc:identifier>
<dc:title><![CDATA[Exploring the Pharmacotherapeutic Options for Treating Type 2 Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>Supplement 3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>65S</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>60S</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/66S?rss=1">
<title><![CDATA[Beyond Glycemic Control: The Effects of Incretin Hormones in Type 2 Diabetes]]></title>
<link>http://tde.sagepub.com/cgi/content/abstract/34/Supplement_3/66S?rss=1</link>
<description><![CDATA[
<p>The improved understanding of glucoregulatory hormones has driven the
development of new pharmacologic agents to treat type 2 diabetes. One new
class of antihyperglycemic medication is incretin mimetics (IMs). Incretin
hormones potentiate insulin secretion following meal ingestion, a process that
is impaired in patients with type 2 diabetes. GLP-1, a 30&ndash;amino acid
peptide incretin hormone, is produced in the L cells of the ileum and colon.
Studies have shown that a 6-week continuous GLP-1 infusion in patients with
type 2 diabetes improved glycemic control and &beta;-cell function and delayed
gastric emptying. Despite the rapid degradation and inactivation of GLP-1 by
the enzyme dipeptidyl peptidase IV (DPP-IV), agents that mimic the actions of
GLP-1 are of great clinical interest. First-in-class IM exenatide, a GLP-1
receptor agonist resistant to DPP-IV inactivation, mimics many beneficial
glucoregulatory effects of GLP-1, such as suppressing glucagon secretion,
regulating gastric emptying and satiety, and increasing glucose-dependent
insulin secretion. Exenatide is an adjunctive therapy for patients who take
metformin, a sulfonylurea, a thiazolidinedione, or a combination of these oral
medications but have not achieved glycemic control. An 82-week, open-label
extension trial has shown that exenatide is well tolerated and that the
benefits, including improved glycemic control, weight loss, and mitigation of
cardiovascular risk factors, are sustained.</p>
]]></description>
<dc:creator><![CDATA[Martin, C. L.]]></dc:creator>
<dc:date>2008-06-04</dc:date>
<dc:identifier>info:doi/10.1177/0145721708319238</dc:identifier>
<dc:title><![CDATA[Beyond Glycemic Control: The Effects of Incretin Hormones in Type 2 Diabetes]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>Supplement 3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>72S</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>66S</prism:startingPage>
<prism:section>Features</prism:section>
</item>

<item rdf:about="http://tde.sagepub.com/cgi/reprint/34/Supplement_3/73S?rss=1">
<title><![CDATA[Posttest Questions]]></title>
<link>http://tde.sagepub.com/cgi/reprint/34/Supplement_3/73S?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-04</dc:date>
<dc:title><![CDATA[Posttest Questions]]></dc:title>
<dc:publisher>American Association of Diabetes Educators</dc:publisher>
<prism:number>Supplement 3</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>74S</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>73S</prism:startingPage>
<prism:section>Features</prism:section>
</item>

</rdf:RDF>